Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.Guangxi Energy established a new energy company, and the enterprise search APP showed that Fengyuan (Pinggui District, Hezhou City) New Energy Co., Ltd. was established recently, with Xie Jianheng as the legal representative and a registered capital of 400 million yuan. Its business scope includes: energy storage technical services; Contract energy management; Big data service; Electric vehicle charging infrastructure operation, etc. Enterprise survey shows that the company is wholly owned by Guangxi Energy.Guangxi Energy established a new energy company, and the enterprise search APP showed that Fengyuan (Pinggui District, Hezhou City) New Energy Co., Ltd. was established recently, with Xie Jianheng as the legal representative and a registered capital of 400 million yuan. Its business scope includes: energy storage technical services; Contract energy management; Big data service; Electric vehicle charging infrastructure operation, etc. Enterprise survey shows that the company is wholly owned by Guangxi Energy.
Coal stocks fluctuated lower Antai Group fell more than 6%, coal stocks fluctuated lower, Antai Group fell more than 6%, and mountain coal international, Dayou Energy, Shaanxi Black Cat, China Coal Energy and Lu 'an Huaneng followed suit.Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Shanghai Gold Exchange: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram. On December 13th, Shanghai Gold Exchange issued a notice saying that NYAuTN12 contract in Shanghai New Zealand was settled on December 13th, 2024. The details of the settlement of the contract are as follows: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram.
Shanghai ranks third in the world! The Global Financial Technology Center Development Index (2024) was released. It was learned from the 6th Shanghai International Forum on Financial Technology that the Shanghai Financial Technology Industry Alliance released the "Global Financial Technology Center Development Index (2024)", which was released for the second consecutive year. The results of this index show that new york, London, Shanghai, Beijing, Shenzhen, Tokyo, Chicago, Hong Kong, Singapore and San Francisco rank among the top ten in the world. The index is mainly composed of indicators such as the development level, development potential and development environment of financial technology, which intuitively reflects the development of financial technology in different cities around the world in quantitative form. Compared with the previous index, the list of the top ten cities remains unchanged, but the gap between the index scores of cities has further narrowed, showing the increasingly fierce competition in the development of financial technology in major cities around the world. (CBN)Mitsubishi electric: We are discussing cooperation with Japanese domestic competitors to develop power chips. Qi Jianqi, president of mitsubishi electric, Japan, said in an interview that the company is discussing cooperation with Japanese domestic competitors to develop power chips. Qi Jianqi said that although the management widely supported the cooperation, the above discussion was blocked at the administrative level and no progress was made. Qi Jianqi pointed out that the power chip industry needs continuous technological innovation, and it is meaningful to cooperate while there is still a chance to win market share. "We should not compete with each other, but need to unite.".The yield of China's 30-year national debt "24 Special National Debt 06" fell below 2%, hitting a new low.
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14